Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, comments on the relationship between achieving transfusion independence and improved overall survival (OS) in patients with myelofibrosis (MF) treated with momelotinib from the MOMENTUM study (NCT04173494). This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
